|48.99||-1.13 / -2.25%|
As of 3:59pm ET
|48.99||0.00 / 0.00%|
The 8 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 60.00, with a high estimate of 82.00 and a low estimate of 54.00. The median estimate represents a +22.47% increase from the last price of 48.99.
The current consensus among 9 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.